Curis, Inc. (CRIS) Strengthens Leadership Team With Appointments of Jaye Viner, M.D. as Chief Medical Officer and Tania Chander, Pharm.D. as VP of Product Development
8/13/2013 9:38:08 AM
Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
LEXINGTON, Mass., Aug. 13, 2013 (GLOBE NEWSWIRE) -- Curis, Inc. (Nasdaq:CRIS), an oncology-focused drug development company seeking to develop next generation targeted drug candidates for the treatment of human cancers, today announced the appointment of Jaye Viner, M.D. as Chief Medical Officer and Executive Vice President. Dr. Viner will be responsible for the leadership of Curis' clinical development strategy and efforts to further the development of its pipeline of proprietary drug candidates. In addition to Dr. Viner's appointment, Curis also announced the appointment of Tania Chander, Pharm.D. as Vice President of Product Development. Dr. Chander will be responsible for project leadership throughout the product development process.
Help employers find you! Check out all the jobs and post your resume.
comments powered by